Literature DB >> 15647725

Racial disparities in nationally notifiable diseases--United States, 2002.

.   

Abstract

Infectious diseases are a major cause of morbidity, mortality, and disability in the United States and often affect racial/ethnic populations disproportionately. Eliminating racial disparities is a goal of many of the national health objectives for 2010. To estimate racial disparities in the incidence of nationally notifiable infectious diseases by race/ethnicity, CDC reviewed 2002 data from the Nationally Notifiable Diseases Surveillance System (NNDSS), collected through the National Electronic Telecommunications System for Surveillance (NETSS). This report summarizes the results of that analysis, which indicated that incidence rates were at least two times greater for blacks than whites for eight of 42 nationally notifiable diseases; however, substantial gaps exist in the reporting of racial/ethnic data for the 42 diseases, which accounted for approximately 1.3 million of the cases reported by NNDSS. Public health practitioners and policy makers might use these results to address disparities in disease rates among blacks and other racial/ethnic populations, but they also should work to close gaps in data reporting to accurately measure progress toward achieving the national health objectives.

Entities:  

Mesh:

Year:  2005        PMID: 15647725

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  22 in total

1.  Short report: Race and rickettsiae: a United States perspective.

Authors:  F Scott Dahlgren; Ramal Moonesinghe; Jennifer H McQuiston
Journal:  Am J Trop Med Hyg       Date:  2011-12       Impact factor: 2.345

2.  Weaving the native web: using social network analysis to demonstrate the value of a minority career development program.

Authors:  Dedra Buchwald; Rhonda Wiegman Dick
Journal:  Acad Med       Date:  2011-06       Impact factor: 6.893

3.  Barriers to racial/ethnic minority application and competition for NIH research funding.

Authors:  Vickie L Shavers; Pebbles Fagan; Deirdre Lawrence; Worta McCaskill-Stevens; Paige McDonald; Doris Browne; Dan McLinden; Michaele Christian; Edward Trimble
Journal:  J Natl Med Assoc       Date:  2005-08       Impact factor: 1.798

4.  Sexually transmitted diseases in the USA: temporal trends.

Authors:  Sevgi O Aral; Kevin A Fenton; King K Holmes
Journal:  Sex Transm Infect       Date:  2007-07       Impact factor: 3.519

5.  Collection of social determinant of health measures in U.S. national surveillance systems for HIV, viral hepatitis, STDs, and TB.

Authors:  Victoria M Beltran; Kathleen McDavid Harrison; H Irene Hall; Hazel D Dean
Journal:  Public Health Rep       Date:  2011 Sep-Oct       Impact factor: 2.792

6.  Race, socioeconomic status, and response to methotrexate treatment of ectopic pregnancy in an urban population.

Authors:  Samantha F Butts; Erika Gibson; Mary D Sammel; Alka Shaunik; Brianna Rudick; Kurt Barnhart
Journal:  Fertil Steril       Date:  2010-08-02       Impact factor: 7.329

Review 7.  Review: Increasing Awareness and Education on Health Disparities for Health Care Providers.

Authors:  Shawna Nesbitt; Rigo Estevan Palomarez
Journal:  Ethn Dis       Date:  2016-04-21       Impact factor: 1.847

8.  Socioeconomic gradients in sexually transmitted diseases: a geographic information system-based analysis of poverty, race/ethnicity, and gonorrhea rates in California, 2004-2006.

Authors:  Yuri P Springer; Michael C Samuel; Gail Bolan
Journal:  Am J Public Health       Date:  2010-04-15       Impact factor: 9.308

9.  Completeness of reporting of race and ethnicity data in the nationally notifiable diseases surveillance system, United States, 2006-2010.

Authors:  Nelson Adekoya; Benedict I Truman; Umed A Ajani
Journal:  J Public Health Manag Pract       Date:  2015 Mar-Apr

Review 10.  The use of cephalosporins for gonorrhea: the impending problem of resistance.

Authors:  Pennan M Barry; Jeffrey D Klausner
Journal:  Expert Opin Pharmacother       Date:  2009-03       Impact factor: 3.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.